- Home
- GHRS vs NBXG Comparison
GHRS vs NBXG Comparison
Compare GHRS & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | NBXG |
|---|---|---|
| Founded | 2018 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 1.0B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GHRS | NBXG |
|---|---|---|
| Price | $27.60 | $15.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $41.38 | N/A |
| AVG Volume (30 Days) | ★ 256.9K | 235.9K |
| Earning Date | 05-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.32 | $12.32 |
| 52 Week High | $25.94 | $17.43 |
Technical Indicators
Market Signals| Indicator | GHRS | NBXG |
|---|---|---|
| Relative Strength Index (RSI) | 73.23 | 44.99 |
| Support Level | $12.88 | $15.13 |
| Resistance Level | N/A | $16.94 |
| Average True Range (ATR) | 1.72 | 0.53 |
| MACD | 0.53 | -0.12 |
| Stochastic Oscillator | 95.38 | 16.15 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in NextGen Companies.